| USD millions | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.7 | 2.2 | 1.7 | 2.2 | 2.0 | 2.0 | −2.6% | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | 1.7 | 2.2 | 1.7 | 2.2 | 2.0 | 2.0 | −2.6% | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 1.1 | 1.0 | 1.0 | 1.2 | 1.0 | 1.0 | +1.8% | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | +105.4% | |
| Operating expenses | 16.5 | 14.5 | 9.0 | 6.6 | 17.6 | 9.9 | −43.9% | |
| Operating income | 0.6 | 1.2 | 0.7 | 1.0 | 1.0 | 0.9 | −7.2% | |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other income / expense | (15.5) | 15.5 | 10.0 | 7.8 | (16.6) | 10.9 | +165.9% | |
| Pre-tax income | (14.8) | 16.7 | 10.7 | 8.8 | (15.6) | 11.9 | +176.3% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | (14.8) | 16.7 | 10.7 | 8.8 | (15.6) | 11.9 | +176.3% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | (1.91) | 2.20 | 1.48 | 1.30 | (2.25) | 1.74 | +177.3% | |
| EPS, diluted (per share) | (1.91) | 2.20 | 1.48 | 1.30 | (2.25) | 1.74 | +177.3% | |
| EBITDA | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.9 | — | |
| Depreciation & amortization | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | — | |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | +0.0 pts | |
| Operating margin | 37.0% | 53.3% | 41.7% | 47.7% | 49.7% | 47.4% | −2.3 pts | |
| Net margin | −865.9% | 759.6% | 625.9% | 401.7% | −759.8% | 595.4% | +1355.1 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
